For the year ending 2025-12-31, MLSS had -$2,145,416 decrease in cash & cash equivalents over the period. -$2,931,751 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -5,722,216 |
| Depreciation expense | 8,853 |
| Amortization of intangibles | 69,341 |
| Stock based compensation | 952,716 |
| Bad debt expense | 11,639 |
| Employees paid in stock | 728,750 |
| Expense paid in stock | 1,020,673 |
| Amortization of right-of-use asset | 107,463 |
| (increase) in accounts receivable | 216,883 |
| Increase in accounts receivable, related parties | 25,548 |
| Increase in inventories | 68,622 |
| (increase ) decrease in advances on contracts | 133,134 |
| Decrease (increase) in prepaid expenses and other current assets | -95,853 |
| Increase in accounts payable | 408,856 |
| Increase in accounts payable, related party | 866,386 |
| (decrease) increase in accrued expenses | -801,116 |
| (decrease) increase in accrued expenses, related party | 115,887 |
| Decrease operating right of use lease asset | 103,751 |
| Net cash used in operating activities | -2,916,627 |
| Purchase of furniture, fixtures, and equipment | 15,124 |
| Net cash (used in) provided by investing activities | -15,124 |
| Proceeds from issuance of convertible notes, related parties | 800,000 |
| Payments finance lease obligations | 13,665 |
| Net cash provided by financing activities | 786,335 |
| Net increase (decrease) in cash and cash equivalents | -2,145,416 |
| Cash and cash equivalents at beginning of period | 3,258,058 |
| Cash and cash equivalents at end of period | 1,112,642 |
MILESTONE SCIENTIFIC INC. (MLSS)
MILESTONE SCIENTIFIC INC. (MLSS)